GB0609588D0 - Nanoparticle Pharmaceutical Carrier - Google Patents
Nanoparticle Pharmaceutical CarrierInfo
- Publication number
- GB0609588D0 GB0609588D0 GBGB0609588.9A GB0609588A GB0609588D0 GB 0609588 D0 GB0609588 D0 GB 0609588D0 GB 0609588 A GB0609588 A GB 0609588A GB 0609588 D0 GB0609588 D0 GB 0609588D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical carrier
- nanoparticle pharmaceutical
- nanoparticle
- carrier
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6925—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Nanotechnology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Optics & Photonics (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0609588.9A GB0609588D0 (en) | 2006-05-13 | 2006-05-13 | Nanoparticle Pharmaceutical Carrier |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0609588.9A GB0609588D0 (en) | 2006-05-13 | 2006-05-13 | Nanoparticle Pharmaceutical Carrier |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0609588D0 true GB0609588D0 (en) | 2006-06-21 |
Family
ID=36637504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0609588.9A Ceased GB0609588D0 (en) | 2006-05-13 | 2006-05-13 | Nanoparticle Pharmaceutical Carrier |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB0609588D0 (en) |
-
2006
- 2006-05-13 GB GBGB0609588.9A patent/GB0609588D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL194095A0 (en) | Drug microparticles | |
GB0607866D0 (en) | Nanostructures | |
PL2059558T4 (en) | Novel nanoparticles | |
EP2057987A4 (en) | Pharmaceutical composition containing statin-encapsulated nanoparticle | |
ZA200809546B (en) | Pharmaceutical compounds | |
EP1992348A4 (en) | Pharmaceutical combination | |
GB0608820D0 (en) | Pharmaceutical compounds | |
EP2084279A4 (en) | Dna-guided nanoparticle assemblies | |
EP1990052A4 (en) | Pharmaceutical package | |
EP2038836A4 (en) | Adverse drug reaction reduction | |
ZA200806318B (en) | Drug combinations | |
IL197883A0 (en) | Combination drug | |
GB0608184D0 (en) | Pharmaceutical compounds | |
GB0608176D0 (en) | Pharmaceutical Compounds | |
GB0608264D0 (en) | Pharmaceutical compounds | |
GB0608175D0 (en) | Pharmaceutical Compounds | |
AP2734A (en) | Pharmaceutical carrier composition and pharmaceutical composition | |
GB0625682D0 (en) | Pharmaceutical compounds | |
GB0622892D0 (en) | Pharmaceutical compounds | |
GB0609588D0 (en) | Nanoparticle Pharmaceutical Carrier | |
GB0622332D0 (en) | Drug | |
ZA200902756B (en) | Combination drug | |
GB0605952D0 (en) | Carrier | |
AP2007004032A0 (en) | Pharmaceutical carrier composition and pharmaceutical composition | |
IL195922A0 (en) | Adverse drug reaction reduction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |